In vivo blood flow abnormalities in the transgenic knockout sickle cell mouse

Journal of Clinical Investigation

Volumn 103, Issue 6, 1999, Pages 915-920

  Embury, Stephen H ^a,e   Mohandas, Narla ^b   Paszty, Chris ^c   Cooper, Philip ^b   Cheung, Anthony T W ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c AMGEN INC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN S;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW VELOCITY; CONTROLLED STUDY; HYPEROXIA; KNOCKOUT MOUSE; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SICKLE CELL ANEMIA; TRANSGENIC MOUSE;

EID: 0033559411     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5977     Document Type: Article

References (38)

1. Herrick, J.B. 1910. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Arch. Int. Med. 6:517-521.
2. Ham, T.H., and Castle, W.B. 1940. Relationship of increased hypotonic fragility of erythrostasis to the mechanisms of hemolysis in certain anemias. Trans. Assoc. Am. Phys. 55:127-132.
3. Dean, J., and Schechter, A.N. 1978. Sickle cell anemia: molecular and cellular basis of therapeutic approaches. N. Engl. J. Med. 299:752-870.
4. Harris, J.W., Brewster, H.H., Ham, T.H., and Castle, W.B. 1956. Studies on the destruction of red blood cells. X. The biophysics and biology of sickle-cell disease. Arch. Int. Med. 97:145-168.
5. Eaton, W.A., and Hofrichter, J. 1990. Sickle cell hemoglobin polymerization. Adv. Prot. Chem. 40:63-279
6. Knisely, M.H., Bloch, E.H., Eliot, T.S., and Warner, L. 1947. Sludged blood. Science. 106:431-440.
7. Fink, A.I., Funahashi, T., Robinson, M., and Watson, R.J. 1961. Conjunctival blood flow in sickle-cell disease. Arch. Ophthalmol. 66:824-829.
8. Lipowsky, H.H., Sheikh, N.U., and Katz, D.M. 1987. Intravital microscopy of capillary microdynamics in sickle cell disease. J. Clin. Invest. 80:117-127.
9. Rodgers, G.P., et al. 1984. Periodic microcirculatory flow in patients with sickle-cell disease. N. Engl. J. Med. 311:1534-1538.
10. Cheung, A.T.W., et al. 1997. Development of a severity index to objectively characterize microvascular abnormalities in sickle cell disease. Blood. 90(Suppl. 1):127A. (Abstr.)
11. Castro, O., Orlin, J., Rosen, M.W., and Finch, S.C. 1973. Survival of human sickle-cell erythrocytes in heterologous species: response to variations in oxygen tension. Proc. Natl. Acad. Sci. USA. 70:2356-2359.
12. Fabry, M. 1994. Transgenic animal models. In Sickle cell disease: basic principles and clinical practice. S.H. Embury, R.P. Hebbel, N. Mohandas, and M.H. Steinberg, editors. Raven Press. New York, NY. 105-120.
13. Kaul, D.K., Fabry, M.E., and Nagel, R.L. 1989. Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications. Proc. Natl. Acad. Sci. USA. 86:3356-3360.
14. Trudel, M., et al. 1991. Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD. EMBO J. 10:3157-3165.
15. Trudel, M., et al. 1990. Towards a mouse model for sickle cell disease: HB SAD. Nouv. Rev. Fr. Hematol. 32:407-408.
16. Nagel, R.L. 1998. A knockout of a transgenic mouse - animal models of sickle cell anemia. N. Engl. J. Med. 339:194-195.
17. Paszty, C., et al. 1997. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science. 278:876-878.
18. Ryan, T.M., Ciavatta, D.J., and Townes, T.M. 1997. Knockout-transgenic mouse model of sickle cell disease. Science. 278:873-876.
19. Messina, E.J., et al. 1994. Increases in oxygen tension evoke artenolar constriction by inhibiting endothelial prostaglandin synthesis. Microvasc. Res. 48:151-160.
20. Kaul, D.K., et al. 1995. In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse. J. Clin. Invest. 96:2845-2853.
21. Fabry, M.E., et al. 1995. A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity. Blood. 86:2419-2428.
22. Cheung, A.T.W., et al. 1997. Microcirculation and metastasis in a new mouse mammary tumor model system. Int. J. Oncol. 11:69-77.
23. Cheung, A.T.W., et al. 1997. Conjunctival microcirculation in sickle cell disease (SCD): a computer-assisted intravital study. Microcirculation. 4:164. (Abstr.)
24. Wayland, K., and Johnson, P. 1967, Erythrocyte velocity measurements in microvessels by a two-slit method. J. Appl. Physiol. 22:333-337.
25. Baker, M., and Wayland, H. 1974. On-line volume flow rate and velocity profile measurement for blood in microvessels. Microvasc. Res. 7:131-143.
26. Seki, J., and Lipowsky, H.H. 1989. In vivo and in vitro measurements of red cell velocity under epifluorescence microscopy. Microvasc. Res. 38:110-124.
27. Lipowsky, H.H., Usami, S., and Chien, S. 1960. In vivo measurements of "apparent viscosity" and microvessel hematocrit in the mesentery of rhe cat. Microvasc. Res. 19:297-319.
28. Kaul, D.K., Fabry, M.E., and Nagel, R.L. 1989. Erythrocytic and vascular factors influencing the microcirculatory behavior of blood in sickle cell anemia. Ann. NY Acad. Sci. 565:316-326.
29. Kaul, D.K., et al. 1983. Erythrocytes in sickle cell anemia are heterogeneous in their rheological and hemodynamic characteristics. J. Clin. Invest. 72:22-29.
30. Chien, S. 1977. Rheology of sickle cells and erythrocyte content. Blood Cells. 3:283-303.
31. Embury, S.H., Hebbel, R.P., Mohandas, N., and Steinberg, M.H. 1994. Pathogenesis of vasoocclusion. In Sickle cell disease: basic principles and clinical practice. S.H. Embury, R.P. Hebbel, N. Mohandas, and M.H. Steinberg, editors. Raven Press. New York, NY. 311-326.
32. Zipursky, A., et al. 1992. Oxygen therapy in sickle cell disease. Am. J. Pediatr. Hematol. Oncol. 14:222-228.
33. Khoury, H., and Grimsley, E. 1995. Oxygen inhalation in nonhypoxic sickle cell patients during vaso-occlusive crisis [letter]. Blood. 86:3998.
34. Embury, S.H., et al. 1984. Oxygen inhalation by subjects with sickle cell anemia. Effects on endogenous erythropoietin kinetics erythropoiesis. N. Engl. J. Med. 311:291-295.
35. Fridovich, I. 1998. Oxygen toxicity: a radical explanation. J. Exp. Biol. 201:1203-1209.
36. Putman, E., van Golde, L.M., and Haagsman, H.P. 1997. Toxic oxidant species and their impact on the pulmonary surfactant system. Lung. 175:75-103.
37. Gonzalez, P., et al. 1997. A phase I/II study of polymerized bovine hemoglobin in adult patients with sickle cell disease not in crisis at the time of study. J. Invest. Med. 45:258-264.
38. Hess, J.R. 1996. Alternative oxygen carriers. Curr. Opin. Hematol. 3:492-497.